Key result
Nurse-led outpatient treatment of deep vein thrombosis using low molecular weight heparin eliminates the historical requirement for inpatient intravenous unfractionated heparin therapy.
The advent of low molecular weight heparin allows for nurse-led outpatient treatment of deep vein thrombosis, replacing the need for inpatient intravenous unfractionated heparin.
Answers are grounded in this paper and cite their sources.
Supports nurse-led outpatient DVT care with LMWH; leaves open confirmation via prospective RCTs before practice change.
Patients with a deep vein thrombosis (DVT) have, historically, been treated initially with intravenous, unfractionated heparin, necessitating inpatient care. The advent of low molecular weight heparin (LMWH) now allows treatment of these patients on an outpatient basis, as the authors explain here.
No takes yet. Share an insight, caveat, or question.
Pout et al. (1999) studied this question. Nurse-led outpatient treatment of deep vein thrombosis using low molecular weight heparin eliminates the historical requirement for inpatient intravenous unfractionated heparin therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: